1.
Senapati J, Daver NG. Response to Comment on: “Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms”. Haematologica 2026; 111(7):2550-2551; https://doi.org/10.3324/haematol.2025.289205.